Lion Biotechnologies (LBIO) Tops Q4 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Lion Biotechnologies (LBIO) PT Lowered to $11 at Jefferies Following 4Q
March 8, 2017 7:25 AM ESTJefferies lowered its price target on Lion Biotechnologies (NASDAQ: LBIO) to $11.00 (from $13.00) while maintaining a Buy rating. LBIO reported 4Q EPS of $(0.25) vs consensus of $(0.22).
Analyst Biren Amin commented, "LBIO reported 4Q16 financials and provided a pipeline update. LN-144 is on track... More
